![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2007, American Society for Microbiology Genome-Wide Analysis of Cellular Response to Bacterial Genotoxin CdtB in Yeast † Department of Applied Molecular Bioscience, Division of Engineering, Yamaguchi University Graduate School of Medicine, Ube 755-8611, Japan *Corresponding author. Mailing address: Department of Applied Molecular Bioscience, Division of Engineering, Yamaguchi University Graduate School of Medicine, Tokiwadai, Ube 755-8611, Japan. Phone: 81 (836) 85-9292. Fax: 81 (836) 85-9201. E-mail: rinji/at/yamaguchi-u.ac.jp. Received August 17, 2006; Revised October 25, 2006; Accepted December 22, 2006. Abstract The cytolethal distending toxins (CDTs) are secreted virulence proteins produced by several bacterial pathogens, and the subunit CdtB has the ability to create DNA lesions, primarily DNA single-strand breaks (SSBs) in vitro, and cause cell cycle arrest, cellular distension, and cell death in both mammalian and yeast cells. To elucidate the components of the mechanisms underlying the response to CdtB-induced DNA lesions, a CdtB expression plasmid was transformed into a series of diploid yeast strains harboring deletions in 4,708 nonessential genes. A total of 4,706 of these clones were successfully transformed, which we have now designated as a systematic transformation array (STA), and were subsequently screened. We identified 61 sensitive strains from the STA whose deleted genes can be categorized into a number of groups, including DNA metabolism, chromosome segregation, vesicular traffic, RNA catabolism, protein translation, morphogenesis, and nuclear transport, as well as one unknown open reading frame. However, only 28 of these strains were found to be sensitive to HO endonuclease, which is known to create a DNA double-strand break (DSB), suggesting that CdtB-induced DNA lesion is not similar to the direct DSB. Amazingly, CdtB expression elicits severe growth defects in haploid yeast cells, but only marginal defects in diploid yeast cells. The presence and absence of genes known to be involved in DNA repair in these genome-wide data reveal that CdtB-induced DNA damage is specifically repaired well in the diploid by homologous recombination but not by other repair mechanisms. Our present results provide insights into how CdtB pathogenesis is linked to eukaryotic cellular functions. The cytolethal distending toxins (CDTs) are secreted virulence proteins produced by a number of bacterial pathogens, including Escherichia coli, Haemophilus ducreyi, Campylobacter spp., Salmonella enterica serovar Typhi, Actinobacillus actinomycetemcomitans, Shigella dysenteriae, and Helicobacter spp. (42, 44, 56). CDTs consist of the three subunits CdtA, CdtB, and CdtC and form a ternary complex (40). CdtB shares conserved residues with the active sites of DNase I-like nucleases, and purified CdtB primarily shows single-strand nicking activity on coiled plasmid DNA and subsequently produces linear DNA in vitro (15, 35, 40). Enzymatically active CdtB induces cell cycle arrest at the G2/M phase, inhibits cell proliferation, and causes cellular enlargement in mammalian cells (28, 40). Biochemical analysis has also demonstrated that DNA damage checkpoint machineries and Rho-type GTPase function are involved in CdtB-induced cell cycle arrest and cellular enlargement (13, 15, 16, 30, 60). However, the entire complement of genes required for the repair of CdtB-induced DNA lesions and also those leading to cell cycle arrest, cellular enlargement, and cell death have not been fully identified. Because Hassane et al. showed that CdtB is active in yeast (Saccharomyces cerevisiae) cells similar to mammalian cells (19), we used the yeast genome to further elucidate and characterize the components of the CdtB response pathway and to illustrate the consequences of CdtB activity in host cells. Genome-wide deletion strains of yeast have now been used in many studies (33, 50, 61), and genome-wide analyses have a number of advantages over their classical genetic counterparts, not only in terms of the greater ease in obtaining global results but also because of their far greater comprehensiveness. Hence, if all of the yeast deletion strains in a particular set are screened for desirable phenomena, the known genes identified in this screening will reveal novel features of the required functions. Moreover, the absence of specific genes can also disclose features of unrelated functions. The value of identifying absent genes in such screening approaches has not been highly emphasized in traditional genetics, even in genome-wide analysis, because these analyses need to be sufficiently systematic to verify that such an absence is not an artifact or due to leakage from the screening filters. In our present study, we have adopted a systematic transformation method that allows us to analyze each deletion strain one by one for the CdtB-induced growth phenotype. This method also allows us to generate a comprehensive series of results for genes required for the CdtB response, which illustrates a genome-wide view of host-pathogen interactions. In comparison with the numerous previous studies of double-strand breaks (DSBs) (26), little is currently known about the repair mechanisms for single-strand breaks (SSBs). Even if there is no direct evidence for SSB creation induced by CdtB expression in vivo, yeast genome-wide analysis will reveal the feature of CdtB-induced DNA lesions by comparison with the responses to the direct DSB that can be created by the ectopic expression of HO endonuclease in yeast (47) and the other DNA damage. In the present study, we report the results of our genome-wide screen of genes required for CdtB response in yeast. We show here that evolutionally conserved mechanisms involving components of homologous recombination (HR), DNA replication, chromosome maintenance, and mRNA decay are required for the response to CdtB. The genes that we identified in this analysis also indicate that there are specific features of CdtB response that do not fully overlap with the components required for direct DSB and other DNA damage. MATERIALS AND METHODS Yeast strains, plasmids, and growth media. Complete homozygous diploid deletion strains (#95401.H1R3) were obtained from Research Genetics (Huntsville, AL). BY4743 (MATa/MATα leu2Δ0/leu2Δ0 ura3Δ0/ura3Δ0 his3Δ1/his3Δ1 met15Δ0/+ +/lys2Δ0) and BY4740 (MATa leu2Δ0 ura3Δ0 lys2Δ0) were used as the parental strains. The diploid W303 strain and isogenic haploid W303-1A strain were also used (57). YPD medium and dropout synthetic medium were prepared using standard procedures (46). The plasmids used were pDCH-CdtB from Campylobacter jejuni (19), YopM (pCFL140) (29) and pRS315 (52). p315GAL-HO was constructed by insertion of the GAL-HO fragment from pGAL-HO (21) into the pRS315 vector. Yeast transformation. Systematic yeast transformation experiments were performed using the S. cerevisiae direct transformation kit (Wako Pure Chemicals, Osaka, Japan), which was originally developed in our laboratory. Yeast deletion strains were grown on YPD square plates and picked using 96-pin QReps (X5052; Genetix, Hampshire, United Kingdom). The selected clones were then inoculated in 25 μl of YPD liquid medium in microplates and grown for 24 h without shaking. Twenty-five microliters of direct transformation solution premixed with plasmid DNA was directly added to each well, and the plates were then vortexed and incubated at 42°C for 2 h. Ten-microliter aliquots of the growth mixtures were spotted on square selection plates using a 96-channel pipetting machine (HT station 500; Cosmotec, Tokyo, Japan). Screening and characterization of CdtB-sensitive strains. Transformant arrays were generated in a 96-well format on square selection plates. The transformed yeast deletion clones were picked, transferred to 50-μl volumes of leucine-dropout medium in 96-well microplates, and incubated at 28°C for 24 h without shaking. These cell cultures were then spotted onto synthetic medium containing 2% glucose, 2% galactose, or 2% raffinose and 2% galactose. For growth assays, deletion strains were grown for 24 h and cell concentrations were adjusted to optical density at 600 nm (OD600) values of 1, 0.1, 0.01 and 0.001. Eight-microliter aliquots of these serial dilutions were then spotted onto galactose or glucose plates. For alternative cell growth and survival assays, the yeast cells were precultured in synthetic dropout liquid medium containing 2% raffinose and then transferred to dropout liquid medium containing 2% raffinose and 2% galactose to give an OD600 of 0.1. After 24 h, OD600 values were measured to compare cell growth, cell suspensions were adjusted to an OD600 value of 0.001, and 100 μl was spread onto YPD plates to compare their survival frequency with that of the CdtB-transformed BY4743 control parental strain. Results were obtained from three independent experiments. For drug sensitivity assays, YPD medium containing 0.25 M hydroxyurea (HU), and 0.2% methyl methanesulfonate (MMS) was used. UV sensitivities were examined by irradiation of spotted serial dilutions of the yeast strains according to a previously described procedure (39). For flow cytometric analysis, cells were fixed with 70% ethanol, washed with phosphate-buffered saline, and incubated with 1 mg/ml RNase. Cells were then suspended in 20 μg/ml of propidium iodide in phosphate-buffered saline. Flow cytometry was performed using FACS Calibur (Becton Dickinson, Franklin Lakes, NJ). RESULTS The impact of ploidy upon CdtB-induced toxicity in yeast. CdtB induces cell cycle arrest during G2/M phase and also causes cellular enlargement in both mammalian and yeast cells (19, 60). We further compared the defects in growth and cell cycle progression in haploid and diploid yeast strains expressing CdtB and found that even in strains of different backgrounds, the CdtB-induced growth defects were severe in haploid cells but not in diploid cells (Fig. (Fig.1A).1A
Genome-wide screening of CdtB sensitive yeast deletion strains. Homozygous nonessential deletion strains were inoculated onto YPD plates, but 84 clones could not be recovered from the frozen stocks. The remaining 4,708 strains were successfully recovered and were transformed with a CdtB-expression plasmid (pDCH-CdtB) via our systematic transformation method (see Materials and Methods). A total of 4,602 strains have been successfully transformed by the initial transformation procedure (Fig. (Fig.2A).2A
The transformant array was then transferred to liquid synthetic dropout medium in 96-well microplates and grown for a further 24 h. The cultures were then spotted onto synthetic glucose (repression) or galactose (induction) plates, except for the 0370, 0371, 0372, and 0380 plates, where 2% raffinose-2% galactose plates were used instead because of the presence of many strains that are slow growing on galactose. In our initial screening, 242 sensitive deletion strains were selected (Fig. (Fig.2B)2B
To examine the possibility that enhanced gene expression was caused by these gene deletions, the 61 selected CdtB-sensitive strains were transformed with a plasmid harboring galactose-inducible YopM, a Yersinia virulence factor (29). None of these mutants was sensitive to YopM (Fig. (Fig.3),3 The genes corresponding to our 61 selected CdtB-sensitive deletion strains could be classified into seven groups and one unknown ORF. The major group comprises genes involved in DNA metabolism, including HR repair genes such as RAD50, RAD51, RAD55, RAD57, RAD59, and XRS2 (27). The absence of RAD52, RAD54, and MRE11 in this group, which are known as HR repair genes, was due to incorrect deletions. We therefore constructed diploid strains with homozygous deletions in these three genes and confirmed that all of them display CdtB sensitivity (data not shown). Our screen also identified all three known complexes for nonessential replication factor C (RFC), which associates with proliferating cell nuclear antigen (PCNA) to form the replication fork structure (34). These complexes comprise Rad24-RFC; the PCNA-like clamp consisting of Rad17, Ddc1, and Mec3; Ctf8/Dcc1-RFC; and Elg1-RFC. We also identified the S-phase checkpoint proteins Tof1 and Mrc1 (32); DNA damage mediator Rad9 (32), the Sae2 regulator (3); the Hpr5 (Srs2) helicase required for recovery from a stalled replication fork (59); another helicase, Sgs1 (23); and the Top3 DNA topoisomerase and Mus81-Mms4 endonuclease required for replication fork stability (4). In addition, proteins such as Bim1, Chl1, Ctf19, and Mcm21, which are required for efficient sister chromatid cohesion (36), were also identified. The additional genes that we identified could be assigned to vesicular traffic and ion homeostasis, RNA catabolism, protein translation, morphogenesis, and nuclear transport groups. Only one unknown ORF, YEL033W, which was previously identified in an ionizing radiation screen (6), was also identified in our current CdtB screen. Cross-sensitivity of CdtB-sensitive strains to other genotoxic agents. To compare the CdtB mode of action with the activity of other genotoxic agents, we examined the sensitivity of our selected CdtB-sensitive strains to HO endonuclease expression, UV irradiation, and hydroxyurea treatment (Fig. (Fig.33
Phenotypic analyses of CdtB-sensitive strains. To examine the phenotypic consequences of CdtB activity, we investigated the growth and survival frequency and the DNA content and cell size distributions (Table 1 and see Fig. S1 in the supplemental material) at 24 h after CdtB induction in our selected CdtB-sensitive yeast strains. In all of our CdtB-sensitive deletion strains, the cell growth and survival frequency were reduced (Table 1). In the DNA damage checkpoint deletion strains (ddc1Δ, mec3Δ, rad9Δ, rad17Δ, and rad24Δ), however, the cell growth was close to wild-type levels but the overall viability was significantly reduced. Consistent with this, these DNA damage checkpoint deletion strains show similar DNA content distributions to CdtB-expressing wild-type cells (Table 1 and see Fig. S1A in the supplemental material). In contrast, deletion strains for S-phase checkpoint (mrc1ΔM and tof1Δ), Elg1-RFC (elg1Δ), and chromosome maintenance proteins (bim1Δ, ctf19Δ, mcm16Δ, mcm21Δ, and mcm22Δ) have higher survival frequencies that are accompanied by the accumulation of cells in G1. Deletion strains for Nam7, Upf3, and Nmd2, which are three tightly interacting proteins required for nonsense-mediated RNA decay (20), accumulated a considerable number of enlarged cells. In addition, deletion strains for vesicular traffic, ion homeostasis, morphogenesis (except for NAT3), protein translation, and nuclear transport genes accumulate large cells (Table 1 and see Fig. S1B in the supplemental material). The absence of known DNA repair gene deletions in the selected list of CdtB-sensitive strains. We speculated that if our genome-wide screen had identified all of the components required for the CdtB response, the lack of known DNA repair genes would implicate a role for unused repair mechanisms in this pathway. We confirmed again that 18 strains harboring deletions in genes responsible for nucleotide excision repair (NER) (RAD1, -2, -4, -7, -10, -14, and -23) (45), postreplication repair (PRR) (RAD5, 06, and -18) (9), base excision repair (BER) (MAG1) (37), and nonhomologous end joining (NHEJ) (TEL1, YKU70, YKU80, POL4, DNL4, LIF1, and NEJ1) (41) were not sensitive to CdtB except for the tel1Δ, yku70Δ, and yku80Δ deletion strains, which showed very weak growth defects (Fig. (Fig.4).4
DISCUSSION STA. In our present study, we transformed a CdtB expression plasmid into 4,706 nonessential diploid deletion strains and the resulting array was used as a comprehensive screen for genes required for the CdtB response (Fig. (Fig.2).2 Genes required for the CdtB response. Our genome-wide analysis of the response to CdtB identified genes involved in HR repair, the DNA damage checkpoint, S-phase checkpoint, Mus81-Mms4 endonuclease, DNA topoisomerase, and DNA helicases (Table 1), but not for the other DNA repair mechanisms such as NER, PRR, and BER (Fig. (Fig.4).4 It was thought previously that HR repair utilizes sister chromatids in haploid cells but can utilize homologous chromosomes in addition to sister chromatids in diploid cells, and thus this response may be optimal in strains with greater ploidy. However, there are only a few reports that describe different sensitivities to DNA-damaging agents between haploid and diploid yeast cells (38, 48). HO endonuclease-induced DSB is preferably repaired by HR, but there is no phenotypic difference between haploid and diploid cells in this response (Fig. (Fig.1).1 Our selected list of CdtB-sensitive deletion strains includes many components that function during S phase. In particular, three nonessential RFC complexes (34) were all found to be sensitive to CdtB, in which only Ctf8/Dcc1-RFC was sensitive to HO endonuclease. In addition, the individual deletion strain of Elg1-RFC did not show significant sensitivity to UV, HU, or HO endonuclease, as shown in our study, nor did it show sensitivity to MMS (5, 25). This suggests that Elg1 is required at least for SSB and replication-induced DSB, but not for other types of DNA damage. Identification of many components that function during S phase suggest that SSB is repaired during S phase, possibly due to the creation of DSBs by the replication of SSBs (Fig. (Fig.5).5
The DNA-damage checkpoint deletion strains (ddc1Δ, mec3Δ, rad9Δ, rad17Δ, and rad24Δ) showed growth close to wild-type levels after the CdtB induction, but the overall viability was significantly reduced (Table 1). Consistent with this, these DNA-damage checkpoint deletion strains show DNA content distributions similar to those of CdtB-expressing wild-type cells (Table 1 and see Fig. S1A in the supplemental material). Growth and cell cycle progression in the presence of CdtB-induced DNA lesions may cause lethal damage in the DNA damage checkpoint deletion strains. In contrast, the strains with deletions for S-phase checkpoint (mrc1ΔM and tof1Δ), Elg1-RFC (elg1Δ), and chromosome maintenance proteins (bim1Δ, ctf19Δ, mcm16Δ, mcm21Δ, and mcm22Δ) have higher viability that is accompanied by the accumulation of cells in G1. We could not explain the accumulation of G1 cells in these strains, but the G1 phase may not be susceptible to the CdtB-induced DNA lesion. Features of CdtB-induced DNA lesions. As shown in the lists in Tables 1 and 2, CdtB analysis in yeast demonstrated specific features for DNA repair machineries. If CdtB creates an SSB in vivo, it produces a DSB during the S phase (Fig. (Fig.5).5 There is a known mammalian SSB repair system that play a role in neurodegenerative diseases (10, 14). This SSB repair machinery involves poly(ADP) ribose, DNA polymerase β, and DNA ligase III, but these have not been found in microorganisms. In neuronal cells, which are nonproliferative and do not enter S phase, a long persistent G1 phase is the only phase of the cell cycle that is evident. Therefore, we speculate that neuronal cells, or cells that remain in G1, require special DNA repair machinery for SSBs, which may be necessary for reducing aberrant mRNAs and the resulting abnormal proteins. CdtB pathogenesis. Although many pathogenic bacteria appear to produce CDT (42, 44, 56), there is no clear association between the action of CDT and disease symptoms. Several genes associated with CdtB virulence have already been identified in mammalian cells (13, 16, 44, 56, 60); we have identified a lot of genes required for the CdtB response by our yeast genome-wide analysis. If CdtB-induced DNA lesions are repaired by HR repair machineries that act predominantly during S phase (31, 32, 34), CdtB seems to be a time bomb for proliferating cells such as T cells, becoming harmful when cells replicate their DNA. Since Actinobacillus CdtB has been known as an immunosuppressive factor capable of impairing human lymphocyte function (51), the sensitivity of lymphocytes to CdtB may be due to their capability for proliferation or HR repair. Many identified genes in this study are conserved from yeast to humans and thus must be involved in the pathogenesis in mammalian cells that occurs in response to CdtB. In conclusion, the yeast genome can be effectively used for the analysis of bacterial virulence factors (58). Furthermore, STA provides geneticists and pathologists with a new tool for the analysis of all yeast and nonyeast genes, and the resulting genome-wide data have the potential to elucidate many of the salient features of gene function and of the associated pathways. In addition, CdtB, which creates a specific DNA lesion, probably an SSB, will become a new tool for the analysis of a novel DNA repair mechanism in diploidy, a common feature of eukaryotic organisms. [Supplemental material]
Acknowledgments We thank Carol L. Pickett, Samuel I. Miller, and Ira Herskowitz for generously donating plasmids. The authors would also like to acknowledge the technical expertise of the DNA Core Facility of the Center for Gene Research, Yamaguchi University, for their valuable assistance during this study. Notes Editor: D. L. Burns Footnotes Published ahead of print on 12 January 2007.†Supplemental material for this article may be found at http://iai.asm.org/. REFERENCES 1. Akada, R., M. Kawahata, and Y. Nishizawa. 2000. Elevated temperature greatly improves transformation of fresh and frozen competent cells in yeast. BioTechniques 28:854-856. [PubMed] 2. Alto, N. M., F. Shao, C. S. Lazar, R. L. Brost, G. Chua, S. Mattoo, S. A. McMahon, P. Ghosh, T. R. Hughes, C. Boone, and J. E. Dixon. 2006. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124:133-145. [PubMed] 3. Baroni, E., V. Viscardi, H. Cartagena-Lirola, G. Lucchini, and M. P. Longhese. 2004. The functions of budding yeast Sae2 in the DNA damage response require Mec1- and Tel1-dependent phosphorylation. Mol. Cell. Biol. 24:4151-4165. [PubMed] 4. Bastin-Shanower, S. A., W. M. Fricke, J. R. Mullen, and S. J. Brill. 2003. The mechanism of Mus81-Mms4 cleavage site selection distinguishes it from the homologous endonuclease Rad1-Rad10. Mol. Cell. Biol. 23:3487-3496. [PubMed] 5. Bellaoui, M., M. Chang, J. Ou, H. Xu, C. Boone, and G. W. Brown. 2003. Elg1 forms an alternative RFC complex important for DNA replication and genome integrity. EMBO J. 22:4304-4313. [PubMed] 6. Bennett, C. B., L. K. Lewis, G. Karthikeyan, K. S. Lobachev, Y. H. Jin, J. F. Sterling, J. R. Snipe, and M. A. Resnick. 2001. Genes required for ionizing radiation resistance in yeast. Nat. Genet. 29:426-434. [PubMed] 7. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523. [PubMed] 8. Birrell, G. W., G. Giaever, A. M. Chu, R. W. Davis, and J. M. Brown. 2001. A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity. Proc. Natl. Acad. Sci. USA 98:12608-12613. [PubMed] 9. Broomfield, S., T. Hryciw, and W. Xiao. 2001. DNA postreplication repair and mutagenesis in Saccharomyces cerevisiae. Mutat. Res. 486:167-184. [PubMed] 10. Caldecott, K. W. 2004. DNA single-strand breaks and neurodegeneration. DNA Repair 3:875-882. [PubMed] 11. Chang, M., M. Bellaoui, C. Boone, and G. W. Brown. 2002. A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage. Proc. Natl. Acad. Sci. USA 99:16934-16939. [PubMed] 12. Christie, K. R., S. Weng, R. Balakrishnan, M. C. Costanzo, K. Dolinski, S. S. Dwight, S. R. Engel, B. Feierbach, D. G. Fisk, J. E. Hirschman, E. L. Hong, L. Issel-Tarver, R. Nash, A. Sethuraman, B. Starr, C. L. Theesfeld, R. Andrada, G. Binkley, Q. Dong, C. Lane, M. Schroeder, D. Botstein, and J. M. Cherry. 2004. Saccharomyces Genome Database (SGD) provides tools to identify and analyze sequences from Saccharomyces cerevisiae and related sequences from other organisms. Nucleic Acids Res. 32:D311-D314. [PubMed] 13. Comayras, C., C. Tasca, S. Y. Pérès, B. Ducommun, E. Oswald, and J. De Rycke. 1997. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect. Immun. 65:5088-5095. [PubMed] 14. El-Khamisy, S. F., G. M. Saifi, M. Weinfeld, F. Johansson, T. Helleday, J. R. Lupski, and K. W. Caldecott. 2005. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 434:108-113. [PubMed] 15. Elwell, C., K. Chao, K. Patel, and L. Dreyfus. 2001. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect. Immun. 69:3418-3422. [PubMed] 16. Frisan, T., X. Cortes-Bratti, E. Chaves-Olarte, B. Stenerlow, and M. Thelestam. 2003. The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell. Microbiol. 5:695-707. [PubMed] 17. Game, J. C., G. W. Birrell, J. A. Brown, T. Shibata, C. Baccari, A. M. Chu, M. S. Williamson, and J. M. Brown. 2003. Use of a genome-wide approach to identify new genes that control resistance of Saccharomyces cerevisiae to ionizing radiation. Radiat. Res. 160:14-24. [PubMed] 18. Hanway, D., J. K. Chin, G. Xia, G. Oshiro, E. A. Winzeler, and F. E. Romesberg. 2002. Previously uncharacterized genes in the UV- and MMS-induced DNA damage response in yeast. Proc. Natl. Acad. Sci. USA 99:10605-10610. [PubMed] 19. Hassane, D. C., R. B. Lee, M. D. Mendenhall, and C. L. Pickett. 2001. Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect. Immun. 69:5752-5759. [PubMed] 20. He, F., A. H. Brown, and A. Jacobson. 1997. Upf1p, Nmd2p, and Upf3p are interacting components of the yeast nonsense-mediated mRNA decay pathway. Mol. Cell. Biol. 17:1580-1594. [PubMed] 21. Herskowitz, I., and R. E. Jensen. 1991. Putting the HO gene to work: practical uses for mating-type switching. Methods Enzymol. 194:132-146. [PubMed] 22. Hsiang, Y., R. Hertzberg, S. Hecht, and L. F. Liu. 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 27:14873-14878. 23. Ira, G., A. Malkova, G. Liberi, M. Foiani, and J. E. Haber. 2003. Srs2 and Sgs1-Top3 suppress crossovers during double-strand break repair in yeast. Cell 115:401-411. [PubMed] 24. Kadyk, L. C., and L. H. Hartwell. 1992. Sister chromatids are preferred over homologs as substrates for recombinational repair in Saccharomyces cerevisiae. Genetics 132:387-402. [PubMed] 25. Kanellis, P., R. Agyei, and D. Durocher. 2003. Elg1 forms an alternative PCNA-interacting RFC complex required to maintain genome stability. Curr. Biol. 13:1583-1595. [PubMed] 26. Krejci, L., L. Chen, S. Van Komen, P. Sung, and A. Tomkinson. 2003. Mending the break: two DNA double-strand break repair machines in eukaryotes. Prog. Nucleic Acid Res. Mol. Biol. 74:159-201. [PubMed] 27. Krogh, B. O., and L. S. Symington. 2004. Recombination proteins in yeast. Annu. Rev. Genet. 38:233-271. [PubMed] 28. Lara-Tejero, M., and J. E. Galan. 2002. Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions. Trends Microbiol. 10:147-152. [PubMed] 29. Lesser, C. F., and S. I. Miller. 2001. Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection. EMBO J. 20:1840-1849. [PubMed] 30. Li, L., A. Sharipo, E. Chaves-Olarte, M. G. Masucci, V. Levitsky, M. Thelestam, and T. Frisan. 2002. The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell. Microbiol. 4:87-99. [PubMed] 31. Lisby, M., A. Antunez De Mayolo, U. H. Mortensen, and R. Rothstein. 2003. Cell cycle-regulated centers of DNA double-strand break repair. Cell Cycle 2:479-483. [PubMed] 32. Longhese, M. P., M. Clerici, and G. Lucchini. 2003. The S-phase checkpoint and its regulation in Saccharomyces cerevisiae. Mutat. Res. 532:41-58. [PubMed] 33. Mager, W. H., and J. Winderickx. 2005. Yeast as a model for medical and medicinal research. Trends Pharmacol. Sci. 26:265-273. [PubMed] 34. Majka, J., and P. M. J. Burgers. 2004. The PCNA-RFC families of DNA clamps and clamp loaders. Prog. Nucleic Acid Res. Mol. Biol. 78:227-260. [PubMed] 35. Mao, X., and J. M. Dirienzo. 2002. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell. Microbiol. 4:245-255. [PubMed] 36. Mayer, M. L., I. Pot, M. Chang, H. Xu, V. Aneliunas, T. Kwok, R. Newitt, R. Aebersold, C. Boone, G. W. Brown, and P. Hieter. 2004. Identification of protein complexes required for efficient sister chromatid cohesion. Mol. Biol. Cell 15:1736-1745. [PubMed] 37. Memisoglu, A., and L. Samson. 2000. Base excision repair in yeast and mammals. Mutat. Res. 451:39-51. [PubMed] 38. Mortimer, R. K. 1958. Radiobiological and genetic studies on a polyploid series (haploid to hexaploid) of Saccharomyces cerevisiae. Radiat. Res. 9:312-326. [PubMed] 39. Myung, K., S. Smith, and R. D. Kolodner. 2004. Mitotic checkpoint function in the formation of gross chromosomal rearrangements in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 101:15980-15985. [PubMed] 40. Ne ić, D., Y. Hsu, and C. E. Stebbins. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429-433. [PubMed]41. Ooi, S. L., D. D. Shoemaker, and J. D. Boeke. 2001. A DNA microarray-based genetic screen for nonhomologous end-joining mutants in Saccharomyces cerevisiae. Science 294:2552-2556. [PubMed] 42. Oswald, E., J. P. Nougayrede, F. Taieb, and M. Sugai. 2005. Bacterial toxins that modulate host cell-cycle progression. Curr. Opin. Microbiol. 8:83-91. [PubMed] 43. Parsons, A. B., R. L. Brost, H. Ding, Z. Li, C. Zhang, B. Sheikh, G. W. Brown, P. M. Kane, T. R. Hughes, and C. Boone. 2004. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22:62-69. [PubMed] 44. Pickett, C. L., and C. A. Whitehouse. 1999. The cytolethal distending toxin family. Trends Microbiol. 7:292-297. [PubMed] 45. Prakash, S., and L. Prakash. 2000. Nucleotide excision repair in yeast. Mutat. Res. 451:13-24. [PubMed] 46. Rose, M. D., F. Winston, and P. Hieter. 1990. Methods in yeast genetics: a laboratory course manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 47. Rudin, N., and J. E. Haber. 1988. Efficient repair of HO-induced chromosomal breaks in Saccharomyces cerevisiae by recombination between flanking homologous sequences. Mol. Cell. Biol. 8:3918-3928. [PubMed] 48. Saeki, T., I. Machida, and S. Nakai. 1980. Genetic control of diploid recovery after gamma-irradiation in the yeast Saccharomyces cerevisiae. Mutat. Res. 73:251-265. [PubMed] 49. Sato, H., D. W. Frank, C. J. Hillard, J. B. Feix, R. R. Pankhaniya, K. Moriyama, V. Finck-Barbancon, A. Buchaklian, M. Lei, R. M. Long, J. Wiener-Kronish, and T. Sawa. 2003. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 22:2959-2969. [PubMed] 50. Scherens, B., and A. Goffeau. 2004. The uses of genome-wide yeast mutant collections. Genome Biol. 5:229. [PubMed] 51. Shenker, B. J., T. McKay, S. Datar, M. Miller, R. Chowhan, and D. Demuth. 1999. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J. Immunol. 162:4773-4780. [PubMed] 52. Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27. [PubMed] 53. Sjögren, C., and K. Nasmyth. 2001. Sister chromatid cohesion is required for postreplicative double-strand break repair in Saccharomyces cerevisiae. Curr. Biol. 11:991-995. [PubMed] 54. Skrzypek, E., T. Myers-Morales, S. W. Whiteheart, and S. C. Straley. 2003. Application of a Saccharomyces cerevisiae model to study requirements for trafficking of Yersinia pestis YopM in eucaryotic cells. Infect. Immun. 71:937-947. [PubMed] 55. Ström, L., H. B. Lindroos, K. Shirahige, and C. Sjögren. 2004. Postreplicative recruitment of cohesin to double-strand breaks is required for DNA repair. Mol. Cell 16:1003-1015. [PubMed] 56. Thelestam, M., and T. Frisan. 2004. Cytolethal distending toxins. Rev. Physiol. Biochem. Pharmacol. 152:111-133. [PubMed] 57. Thomas, B. J., and R. Rothstein. 1989. Elevated recombination rates in transcriptionally active DNA. Cell 56:619-630. [PubMed] 58. Valdivia, R. H. 2004. Modeling the function of bacterial virulence factors in Saccharomyces cerevisiae. Eukaryot. Cell 3:827-834. [PubMed] 59. Vaze, M. B., A. Pellicioli, S. E. Lee, G. Ira, G. Liberi, A. Arbel-Eden, M. Foiani, and J. E. Haber. 2002. Recovery from checkpoint-mediated arrest after repair of a double-strand break requires Srs2 helicase. Mol. Cell 10:373-385. [PubMed] 60. Whitehouse, C. A., P. B. Balbo, E. C. Pesci, D. L. Cottle, P. M. Mirabito, and C. L. Pickett. 1998. Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block. Infect. Immun. 66:1934-1940. [PubMed] 61. Winzeler, E. A., D. D. Shoemaker, A. Astromoff, H. Liang, K. Anderson, B. Andre, R. Bangham, R. Benito, J. D. Boeke, H. Bussey, A. M. Chu, C. Connelly, K. Davis, F. Dietrich, S. W. Dow, M. El-Bakkoury, F. Foury, S. H. Friend, E. Gentalen, G. Giaever, J. H. Hegemann, T. Jones, M. Laub, H. Liao, N. Liebundguth, D. J. Lockhart, A. Lucau-Danila, M. Lussier, N. M'Rabet, P. Menard, M. Mittmann, C. Pai, C. Rebischung, J. L. Revuelta, L. Riles, C. J. Roberts. P. Ross-MacDonald, B. Scherens, M. Snyder, S. Sookhai-Mahadeo, R. K. Storms, S. Veronneau, M. Voet, G. Volckaert, T. R. Ward, R. Wysocki, G. S. Yen, K. Yu, K. Zimmermann, P. Philippsen, M. Johnston, and R. W. Davis. 1999. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285:901-906. [PubMed] 62. Xu, H., C. Boone, and H. L. Klein. 2004. Mrc1 is required for sister chromatid cohesion to aid in recombination repair of spontaneous damage. Mol. Cell. Biol. 24:7082-7090. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Curr Opin Microbiol. 2005 Feb; 8(1):83-91.
[Curr Opin Microbiol. 2005]Trends Microbiol. 1999 Jul; 7(7):292-7.
[Trends Microbiol. 1999]Rev Physiol Biochem Pharmacol. 2004; 152():111-33.
[Rev Physiol Biochem Pharmacol. 2004]Nature. 2004 May 27; 429(6990):429-33.
[Nature. 2004]Infect Immun. 2001 May; 69(5):3418-22.
[Infect Immun. 2001]Trends Pharmacol Sci. 2005 May; 26(5):265-73.
[Trends Pharmacol Sci. 2005]Genome Biol. 2004; 5(7):229.
[Genome Biol. 2004]Science. 1999 Aug 6; 285(5429):901-6.
[Science. 1999]Prog Nucleic Acid Res Mol Biol. 2003; 74():159-201.
[Prog Nucleic Acid Res Mol Biol. 2003]Mol Cell Biol. 1988 Sep; 8(9):3918-28.
[Mol Cell Biol. 1988]Cell. 1989 Feb 24; 56(4):619-30.
[Cell. 1989]Infect Immun. 2001 Sep; 69(9):5752-9.
[Infect Immun. 2001]EMBO J. 2001 Apr 17; 20(8):1840-9.
[EMBO J. 2001]Genetics. 1989 May; 122(1):19-27.
[Genetics. 1989]Methods Enzymol. 1991; 194():132-46.
[Methods Enzymol. 1991]Proc Natl Acad Sci U S A. 2004 Nov 9; 101(45):15980-5.
[Proc Natl Acad Sci U S A. 2004]Infect Immun. 2001 Sep; 69(9):5752-9.
[Infect Immun. 2001]Infect Immun. 1998 May; 66(5):1934-40.
[Infect Immun. 1998]Science. 1999 Aug 6; 285(5429):901-6.
[Science. 1999]EMBO J. 2001 Apr 17; 20(8):1840-9.
[EMBO J. 2001]Nucleic Acids Res. 2004 Jan 1; 32(Database issue):D311-4.
[Nucleic Acids Res. 2004]Annu Rev Genet. 2004; 38():233-71.
[Annu Rev Genet. 2004]Prog Nucleic Acid Res Mol Biol. 2004; 78():227-60.
[Prog Nucleic Acid Res Mol Biol. 2004]Mutat Res. 2003 Nov 27; 532(1-2):41-58.
[Mutat Res. 2003]Mol Cell Biol. 2004 May; 24(10):4151-65.
[Mol Cell Biol. 2004]Mol Cell. 2002 Aug; 10(2):373-85.
[Mol Cell. 2002]Nat Biotechnol. 2004 Jan; 22(1):62-9.
[Nat Biotechnol. 2004]Mol Cell Biol. 1997 Mar; 17(3):1580-94.
[Mol Cell Biol. 1997]Mutat Res. 2000 Jun 30; 451(1-2):13-24.
[Mutat Res. 2000]Mutat Res. 2001 Aug 9; 486(3):167-84.
[Mutat Res. 2001]Mutat Res. 2000 Jun 30; 451(1-2):39-51.
[Mutat Res. 2000]Science. 2001 Dec 21; 294(5551):2552-6.
[Science. 2001]Nucleic Acids Res. 1979 Nov 24; 7(6):1513-23.
[Nucleic Acids Res. 1979]Biotechniques. 2000 May; 28(5):854-6.
[Biotechniques. 2000]Cell. 2006 Jan 13; 124(1):133-45.
[Cell. 2006]EMBO J. 2001 Apr 17; 20(8):1840-9.
[EMBO J. 2001]Trends Pharmacol Sci. 2005 May; 26(5):265-73.
[Trends Pharmacol Sci. 2005]Prog Nucleic Acid Res Mol Biol. 2003; 74():159-201.
[Prog Nucleic Acid Res Mol Biol. 2003]Nat Genet. 2001 Dec; 29(4):426-34.
[Nat Genet. 2001]Proc Natl Acad Sci U S A. 2001 Oct 23; 98(22):12608-13.
[Proc Natl Acad Sci U S A. 2001]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16934-9.
[Proc Natl Acad Sci U S A. 2002]Radiat Res. 2003 Jul; 160(1):14-24.
[Radiat Res. 2003]Radiat Res. 1958 Sep; 9(3):312-26.
[Radiat Res. 1958]Mutat Res. 1980 Dec; 73(2):251-65.
[Mutat Res. 1980]Genetics. 1992 Oct; 132(2):387-402.
[Genetics. 1992]Curr Biol. 2001 Jun 26; 11(12):991-5.
[Curr Biol. 2001]Mol Cell. 2004 Dec 22; 16(6):1003-15.
[Mol Cell. 2004]Prog Nucleic Acid Res Mol Biol. 2004; 78():227-60.
[Prog Nucleic Acid Res Mol Biol. 2004]EMBO J. 2003 Aug 15; 22(16):4304-13.
[EMBO J. 2003]Curr Biol. 2003 Sep 16; 13(18):1583-95.
[Curr Biol. 2003]Nat Biotechnol. 2004 Jan; 22(1):62-9.
[Nat Biotechnol. 2004]Mol Cell Biol. 1997 Mar; 17(3):1580-94.
[Mol Cell Biol. 1997]Infect Immun. 2001 Sep; 69(9):5752-9.
[Infect Immun. 2001]DNA Repair (Amst). 2004 Aug-Sep; 3(8-9):875-82.
[DNA Repair (Amst). 2004]Nature. 2005 Mar 3; 434(7029):108-13.
[Nature. 2005]Curr Opin Microbiol. 2005 Feb; 8(1):83-91.
[Curr Opin Microbiol. 2005]Trends Microbiol. 1999 Jul; 7(7):292-7.
[Trends Microbiol. 1999]Rev Physiol Biochem Pharmacol. 2004; 152():111-33.
[Rev Physiol Biochem Pharmacol. 2004]Infect Immun. 1997 Dec; 65(12):5088-95.
[Infect Immun. 1997]Cell Microbiol. 2003 Oct; 5(10):695-707.
[Cell Microbiol. 2003]Eukaryot Cell. 2004 Aug; 3(4):827-34.
[Eukaryot Cell. 2004]Nat Biotechnol. 2004 Jan; 22(1):62-9.
[Nat Biotechnol. 2004]